Michael A. Ross MD FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.

Slides:



Advertisements
Similar presentations
JCAHO EXPECTATIONS FOR PRIMARY STROKE CENTER
Advertisements

Stroke Workshop Case Scenario.
Michael A. Ross, MD 1 Evaluating ED Patients with Transient Ischemic Attack: Inpatient vs. Outpatient Strategies.
Michael Ross, MD, FACEP The Management of ED TIA Patients: Michael A. Ross MD FACEP Associate Professor Emergency Medicine Department of Emergency Medicine.
Management of Stroke and Transient Ischaemic Attack Sam Thomson.
Latha G. Stead, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Canadian Best Practice Recommendations for Stroke Care (Updated 2008) Section # 3 Hyperacute Stroke Management Canadian Best Practice Recommendations for.
STROKESTROKESTROKESTROKE. Why Change? Improve Mortality Improve Mortality Devastating and Life Altering Devastating and Life Altering Cost expense of.
1 Sixty-Four-Slice Computed Tomography of the Coronary Arteries: Cost-Effectiveness Analysis of Patients Presenting to the ED with Low Risk Chest Pain.
The Efficacy of Non-invasive Diagnostic for CAD in PMK Hospital Maj. Hutsaya Prasitdumrong, M.D. Cardiovascular Division, Department of Internal Medicine,
Stroke Mark Sudlow Consultant and Senior Lecturer
ED TIA Patient Case Presentation Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral.
Canadian Cardiovascular Society Antiplatelet Guidelines
Primary Care & Obesity Appathurai Balamurugan, MD, MPH Medical Director/Associate Director for Science Chronic Disease Branch/Center for Health Advancement.
Andrew W. Asimos, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Atrial Fibrillation in Patients with Cryptogenic Stroke Gladstone DJ et al. N Engl J Med 2014; 370: Presented by Kris Huston | July 21, 2014.
National rapid access to best-quality stroke services Prevent 1 stroke every day Avoid death or dependence in 1 patient every day National Stroke Clinical.
Edward P. Sloan, MD, MPH FACEP ED Transient Ischemic Attack Patient Management: What Role for Outpatient Evaluation and Disposition?
J. Stephen Huff, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
Management of E.D. Patients who Present with a Transient Ischemic Attack or.
The Management of ED TIA Patients:
University of Michigan
Brian J. O’Neil MD, FACEP The Management of TIA Patients: The Science and the Practice.
An Emergency Department Diagnostic Protocol For Patients With Transient Ischemic Attack: A Randomized Controlled Trial Michael A. Ross MD Scott Compton.
Preventing Strokes One at a Time Evaluating the Event 2009.
FERNE/EMRA The Management of ED TIA Patients: What is the optimal outpatient work-up, treatment and disposition?
Michael Ross, MD, FACEP The Management of ED TIA Patients: Can We Send Them Home, and What Work-up Must Be Done First?
“Six Publications That Influence Neurological Emergency Patient Resuscitation in 2010”
Acute Ischemic Stroke Management: 2004 Emergency Medicine Perspectives.
ACEP Clinical Policy: ACEP Clinical Policy: Critical Issues for the Evaluation and Management of Adult Patients Presenting With Seizures William C. Dalsey,
Jonathan A. Edlow, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral.
Transient Ischemic Attack (TIA): The Calm Before the Storm
Andrew Asimos, MD, FACEP ED Transient Ischemic Attack Patient Management: Can At-risk Ischemic Stroke Patients Be Identified?
A Case of a Thunderclap Headache Andy Jagoda, MD, FACEP.
Stroke Quality Measures Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: May, 2012 Most recently updated: October,
Consultant Neurologist,
Secondary prevention after a TIA or ischemic stroke.
Rashad MAHMUDOV Central Hospital of Oilworkers, Baku-Azerbaijan
Andrew W. Asimos, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Ischemic Stroke without Infarctions: Occlusion and stenosis of carotid arteries ASN Conference September 12 th, 2013.
Benefits of Urgent Evaluation and Treatment for TIA and Minor Stroke Summary and Comment by Kristi L. Koenig, MD, FACEP Published in Journal Watch Emergency.
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
1 EFFECT STUDY 2 EFFECT STUDY  Set national cardiac care benchmarks for hospitals to work towards 
Acute Stroke: Principles of Modern Management A program of the American Academy of Neurology The AAN Acute Stroke Management courses are supported in part.
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Treatment of Ischaemic Stroke The American Heart Association American Stroke Association Guidelines Stroke. 2007;38:
Adult Medical-Surgical Nursing Neurology Module: Cerebrovascular Disease I (TIA)
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
Clinical Overview Director, Stanford Stroke Center Stanford University Palo Alto, California Gregory W. Albers, MD.
Update on TIA Kath Pasco October  Primary prevention has been effective in fall in incidence of first stroke  Major improvements still required.
ACC/AHA 2006 guidelines on the management of PAD.
Objective To assess the impact of the increasing use of MDCT angiography in the setting of blunt and penetrating neck trauma on the use of digital subtraction.
The Case for Rate Control: In the Management of Atrial Fibrillation Charles W. Clogston, M.D. Cardiologist CHI St. Vincent Heart Clinic Arkansas April.
Cerebrovascular Disease Nicholas Cascone, PA-C. Stroke – general characteristics  3 rd most common cause of death in US  Higher incidence in men, blacks,
Rikki Weems, PGY III August 20, 2015
Carotid Disease – Stent vs Surgery vs Medical Therapy? Mehdi H. Shishehbor, DO, MPH, PhD Director, Endovascular Services Interventional Cardiology & Vascular.
Simon Howard Medical Management of Acute Stroke. Fast Recognition of Stroke With sudden onset neurological symptoms: 'FAST' should be used to screen for.
Why Treat Patent Forman Ovale Clifford J Kavinsky, MD, PHD Professor of Medicine and pediatrics Associate Director, Center for Congenital and Structural.
Emergency Medicine Junior Teaching Programme Aberdeen Royal Infirmary Adult Syncope Evaluation in the Emergency Department Jamie Cooper Teaching 4 th March.
Atrial Fibrillation Jay H. Lee, MD Denver Health Medical Center Wednesday 2 July 2008.
Dr. Quan, Dr. Mirhashemi, Dr. Chiang
Risk Stratification of Chest Pain: Best Practices
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Cerebrovascular Disorders
Quality of Referrals Guideline Congruence of referrals to TIAMS clinic
Jennifer Koay, MD Assistant Professor Department of Radiology
The Role of Induced Hypertension and Hyperbaric Oxygen Therapy in Moyamoya Disease: A Case Report Smeer Salam, MD; Lisa Pabst, MD; Sushil Lakhani, MD;
TIA/Stroke (1) C.L.I.P.S. Why do we care?
EMERGENCY Awn khawaldeh.
Presentation transcript:

Michael A. Ross MD FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia

Michael A. Ross MD FACEP Rapid TIA Patient Evaluation in US Emergency Departments and Observation Units: 2008 Opportunities

Michael A. Ross MD FACEP Rapid Evaluation of TIA in U.S. Emergency Departments and Observation Units Michael A. Ross MD FACEP Associate Professor Emergency Medicine Medical Director, Observation Medicine Department of Emergency Medicine Emory University School of Medicine

Michael A. Ross MD FACEP CME Disclosure Statement Research support from the Foundation for Education and Research in Neurologic Emergencies (FERNE) and Emergency Medicine Foundation (EMF)

Michael A. Ross MD FACEP Course Objectives: 1.Learn what interventions are needed for TIA patients beyond the initial ED evaluation. 2.Know what outcomes may be expected from an EDOU diagnostic protocol for TIA patients 3.Understand what resources are needed to implement TIA protocol

Michael A. Ross MD FACEP Case presentation A 58 year old female presents to the emergency department after developing dysarthria, diploplia, numbness, and pronounced weakness of the right face and hand that lasted roughly 12 minutes. The patient feels completely normal and only came in at her families insistence. –Review of systems - mild headache with event. No palpitations, chest pain, or SOB. –Past medical history - Positive for hypertension and hyperlipidemia. No prior stroke or TIA. –Family history positive for premature coronary disease. –Meds - Beta-blocker for HTN. Not on aspirin. –Social - She does not smoke.

Michael A. Ross MD FACEP Case presentation Phyisical Exam: On examination the patient was normotensive, and comfortable. HEENT exam showed no facial or oral asymmetry or numbness. No scalp tenderness. CHEST exam showed no murmurs and a regular rhythm, ABDOMINAL and EXTREMITY exam was normal, NEUROLOGICAL exam showed normal mentation, CN II-XII normal as tested, motor / sensory exam normal, symmetrical normal reflexes, and normal cerebellar exam.

Michael A. Ross MD FACEP Case presentation ED course: –ECG showed a normal sinus rhythm with mild LVH. –Non-contrast head CT scan was normal. –Blood-work (CBC with differential, electrolytes, BUN/Cr, and glucose) was normal. ESR was normal. –Monitor showed no dysrhythmias –Normal subsequent neurological symptoms. –The patient feels fine and is wondering if she can go home. What do you think?

Michael A. Ross MD FACEP Background 300,000 TIAs occur annually 10.5% suffer a stroke within 90 days of an ED visit Stroke is preceded by TIA in 15% of pts Stroke is the THIRD leading cause of death –National cost of stroke = $51 billion annually!

Michael A. Ross MD FACEP TIA STROKE

Michael A. Ross MD FACEP Management of TIA: Areas of Certainty: –Need for ED visit, ECG, labs, Head CT Areas of less certainty –The timing of the carotid dopplers –The need for echocardiography Areas of Uncertainty - Johnston SC. N Engl J Med. 2002;347: –“The benefit of hospitalization is unknown... Observation units within the ED... may provide a more cost-effective option.”

Michael A. Ross MD FACEP To determine if TIA patients will experience: shorter length of stays lower costs comparable clinical outcomes... relative to traditional inpatient admission.

Michael A. Ross MD FACEP Setting: William Beaumont Hospital: A high-volume university-affiliated suburban teaching hospital –Emergency department 2005 ED census = 115,894 –ED observation unit = 21 beds Emergency physician - “admitting” physician for all patients

Michael A. Ross MD FACEP Patient population : Presented to the ED with symptoms of TIA ED evaluation: –History and physical –ECG, monitor, HCT –Appropriate labs –Diagnosis of TIA established Decision to admit or observe SCREENING AND RANDOMIZATION

Michael A. Ross MD FACEP Methods: ADP Exclusion criteria Persistent acute neurological deficits Crescendo TIAs Positive HCT Known embolic source (including a. fib) Known carotid stenosis (>50%) Non-focal symptoms Hypertensive encephalopathy / emergency Prior stroke with large remaining deficit Severe dementia or nursing home patient Social issues making ED discharge / follow up unlikely History of IV drug use

Michael A. Ross MD FACEP TIA Protocol Development process: –Consensus group: Emergency medicine, Neurology, Vascular Surgery, Cardiology, Radiology, Internal Medicine. –Protocol development: Literature search, consensus protocol, pre-study pilot testing phase (>1year), study phase. BOTH study groups had orders for the same four components Methods: ADP Interventions

Michael A. Ross MD FACEP Accelerated Diagnostic Protocol (ADP) in an ED Observation Unit (EDOU) Ross MA et al. Ann Emerg Med 2007;50(2):

Michael A. Ross MD FACEP Methods: ADP Disposition criteria Home –No recurrent deficits, negative workup –Appropriate antiplatelet therapy and follow-up Inpatient admission from EDOU –Recurrent symptoms or neuro deficit –Surgical carotid stenosis (ie >50%) –Embolic source requiring treatment (anticoagulation) –Unable to safely discharge patient

Michael A. Ross MD FACEP Medical management Medical management Antiplatelet Therapy Useful in non-cardioembolic causes – Aspirin mg/day – Clopidogrel or ticlopidine – Aspirin plus dipyridamole Latter two if ASA intolerant or if TIA while on ASA

Michael A. Ross MD FACEP Medical management Medical management Risk Factor Management HTN: BP below 140/90 DM: fasting glucose < 126 mg/dl Hyperlipidemia: LDL < 100 mg/dl Stop smoking! Exercise min, 3x/week Avoid excessive alcohol use Weight loss: < 120% of ideal weight

Michael A. Ross MD FACEP Results

Results: Performance of clinical testing

Michael A. Ross MD FACEP Results: Length of Stay Median Inpatient = 61.2 hr ADP = 25.6 hr Difference= 29.8 hr (Hodges-Lehmann, p<0.001) ADP sub-groups: ADP - home= 24.2 hr ADP - admit= hr

Michael A. Ross MD FACEP Results: 90-Day Clinical Outcomes

Michael A. Ross MD FACEP Outcomes of Index Visit Clinical Testing: ADP in EDOU versus Inpatient Admission Ross MA et al. Ann Emerg Med 2007;50(2):

Michael A. Ross MD FACEP 90 Day Clinical Outcomes: ADP in EDOU versus Inpatient Admission Ross MA et al. Ann Emerg Med 2007;50(2): % incidence of stroke at 90 days –3% after discharge

Michael A. Ross MD FACEP Results: 90 - day Costs Median: Inpatient = $1548 ADP = $890 Difference= $540 (Hodges-Lehmann, p<0.001) ADP sub-groups: ADP - home= $844 ADP - admit= $2,737

Michael A. Ross MD FACEP Study conclusion: Compared to inpatient admission, the ED TIA diagnostic protocol was: More efficient Less costly With comparable (or better) outcomes

Michael A. Ross MD FACEP Unanswered questions: 1.With newer TIA risk scores and imaging, what is the optimal ADP for 2009? 2.Will an ADP for TIA follow the Chest Pain experience and show: –Improved patient satisfaction ? –Improved quality of life? –Improved hospital resource availability? 3.Do findings from the EXPRESS and SOS-TIA studies apply to the ADP? –Lower rates of stroke compared with traditional care

Michael A. Ross MD FACEP Unanswered questions: Unanswered questions: 4. Can an ADP be used for patients with a very small clinical stroke (ie NIHSS<2)? Comparable 90 day risk Lancet Neurol 2006; 5: 323–31 Subsequent stroke rate for patients with TIA vs small stroke

Michael A. Ross MD FACEP Hospital Resources Needed for the TIA ADP 1.Rapid Treatment Unit / Area for Patients –Appropriate staffing, ECG monitoring 2.Carotid imaging availability –MRI/MRA or CTA – Nice if you have them –Doppler – Adequate as an alternative 3.Echocardiography for selected patients –Timing and need for echo remains unclear 4.Neurology consultation availability

Michael A. Ross MD FACEP Imaging modality ProsCons Carotid artery doppler and B- mode ultrasound  Present screening standard  Lowest cost  No radiation / contrast  Need an ACR or ICAVL accredited lab  Timeliness of availability  No associated brain imaging  Clarity of report information  Does not identify carotid dissection CTA of head /neck  May be coupled with initial HCT  Potential 24/7 availability  Fast  Accurate vascular imaging  Imaging of both head and neck vessels  May provide perfusion information  Higher cost  Contrast / renal failure issues  Much more radiation  Limited evidence to support as an alternative to doppler  More “back-end” reformatting work involved MRI / MRA of head/neck  May be coupled with brain MRI (superior brain imaging)  May be done if doppler / CTA is not available or contraindicated (ie CRF)  Imaging of both head and neck vessels  May provide perfusion information  Higher cost  Longer imaging acquisition time  Patient tolerance - metal implants / claustrophobia  Timeliness of availability  Minor contrast / renal failure issues (may be done without if needed)

Michael A. Ross MD FACEP National Feasibility National feasibility of ADP: –18% of EDs have an EDOU –220 JCAHO stroke centers –380 SCPC accredited CPCs Learning from these models - Hospitals with ADP resources may have: –More inpatient beds –More competitive market –Higher volume –More likely to be urban

Michael A. Ross MD FACEP Economic Implications – U.S. Health Care Costs National health care costs –“Hospital Care” accounts for the largest portion of US health care (30%) –Potential savings: If only 18% used ADP = $29 million If all used ADP = $161 million –Medicare is now paying hospitals for the observation of ALL conditions (including TIA) with APC 8003 Effective January

Michael A. Ross MD FACEP CLINICAL CASE - OUTCOME The patient was started on aspirin and admitted to the ED observation unit. While in the unit she had a 2-D echo with bubble contrast, that was normal. She had no arrhythmia detected on cardiac monitoring and no subsequent neurological deficits. However, carotid dopplers were abnormal. She showed 30-50% stenosis of the right internal carotid artery, and a severe flow limiting >70% stenosis of the left carotid artery at the origin of the internal carotid artery. She was admitted to the hospital for endarterectomy. Five days following ED arrival, and following inpatient pre-operative clearance, she underwent successful endarterectomy. On one month follow-up she was asymptomatic and her carotids were doing well.

Michael A. Ross MD FACEP Conclusions TIAs are ominous –Justifies acute interventions, including hospitalization –Opportunity to prevent injury “TIAs” are heterogeneous in origin –Management should be individualized –Prognostic scores and newer imaging may help Secondary prevention is critical

Michael A. Ross MD FACEP Questions?? Questions?? ferne_clindec_2008_tia_ross_observation_extended_062508_final